Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
aDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA
bDepartment of Urology, University of Washington, Seattle, DC 98915, USA
cDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z1M9, Canada
dDepartment of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California Davis, Sacramento, CA 95817, USA
eComprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA
fVA Northern California Health Care System-Mather, Mather, CA 95655, USA
* Corresponding author.
收起